Assessment of non-reperfused and reperfused myocardial infarction using diffusible or deposited radiolabelled perfusion imaging agents

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 3, 2007, Pages 330-337

  Riou, L M ^a   Broisat, A ^a   Lartizien, C ^b   Toufektsian, M C ^a   Maitrejean, S ^c   Janier, M ^b   Vanzetto, G ^a   Fagret, D ^a   Ghezzi, C ^a  

^a UNIV GRENOBLE ALPES   (France)

^b CERMEP IMAGERIE DU VIVANT   (France)

^c Biospace Mesures   (France)

Author keywords

Myocardial blood flow; Myocardial infarction; Nuclear imaging; Radiopharmaceuticals

Indexed keywords

N ETHOXYDITHIOCARBAMATE TC 99M; PENTETATE TECHNETIUM TC 99M; PLASMA PROTEIN; RADIOACTIVE MICROSPHERE; TECHNETIUM 99M; THALLIUM 201; UNCLASSIFIED DRUG;

ANIMAL EUTHANASIA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DIFFUSION; EX VIVO STUDY; HEART EDEMA; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE BLOOD FLOW; HUMAN; HUMAN CELL; ISOTOPE LABELING; MALE; NONHUMAN; RAT; REPERFUSION INJURY; STATISTICAL SIGNIFICANCE;

EID: 33847127411     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0230-3     Document Type: Article

References (35)

1. Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 1989;80:1846-61.
2. Kloner RA, Ganote CE, Jennings RB. The "no-reflow" phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974;54:1486-508.
3. Matsumura K, Jeremy RW, Schaper J, Becker LC. Progression of myocardial necrosis during reperfusion of ischemic myocardium. Circulation 1998;97:795-804.
4. Reffelmann T, Hale SL, Dow JS, Kloner RA. No-reflow phenomenon persists long-term after ischemia/reperfusion in the rat and predicts infarct expansion. Circulation 2003;108: 2911-7.
5. Rochitte CE, Lima JA, Bluemke DA, Reeder SB, McVeigh ER, Furuta T, et al. Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction. Circulation 1998;98:1006-14.
6. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, et al. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-8.
7. Baks T, van Geuns RJ, Biagini E, Wielopolski P, Mollet NR, Cademartiri F, et al. Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular wall characteristics. J Am Coll Cardiol 2006;47: 40-4.
8. Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998;97:765-72.
9. Beller GA. First annual Mario S. Verani, MD, Memorial Lecture: clinical value of myocardial perfusion imaging in coronary artery disease. J Nucl Cardiol 2003;10:529-42.
10. 201Tl SPECT imaging. Radiology 2004;232:49-57.
11. Ammann P, Naegeli B, Rickli H, Buchholz S, Mury R, Schuiki E, et al. Characteristics of patients with abnormal stress technetium Tc 99 m sestamibi SPECT studies without significant coronary artery diameter stenoses. Clin Cardiol 2003; 26:521-4.
12. Fagret D, Marie PY, Brunotte F, Giganti M, Le Guludec D, Bertrand A, et al. Myocardial perfusion imaging with technetium-99m-Tc-NOET: comparison with thallium-201 and coronary angiography. J Nucl Med 1995;36:936-43.
13. Ghezzi C, Fagret D, Arvieux CC, Mathieu JP, Bontron R, Pasqualini R, et al. Myocardial kinetics of TcN-NOET: a neutral lipophilic complex tracer of regional myocardial blood flow. J Nucl Med 1995;36:1069-77.
14. Pasqualini R, Duatti A, Bellande E, Comazzi V, Brucato V, Hoffschir D, et al. Bis(dithicarbamato) nitrido technetium-99m radiopharmaceuticals: a class of neutral myocardial imaging agents. J Nucl Med 1994;35:334-41.
15. 99mTcN-NOET in healthy volunteers. J Nucl Med 2000;41:141-8.
16. 99mTcN-NOET in normal, ischemic-reperfused and membrane-disrupted rat myocardium. J Nucl Cardiol 1996;3:42-54.
17. Johnson G, Nguyen KN, Pasqualini R, Okada RD. Interaction of technetium-99m-N-NOET with blood elements: potential mechanism of myocardial redistribution. J Nucl Med 1997;38:138-43.
18. 99mTcN-NOET in cardiomyocytes from newborn rats: calcium channel interaction. Circulation 1998;98:2591-7.
19. 99mTcN-NOET. J Nucl Med 2003;44:1092-8.
20. 99mTc-N-NOEt myocardial uptake reflects myocardial blood flow and not viability in dogs with reperfused acute myocardial infarction. Circulation 2000;101:2424-30.
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
22. 201Tl and myocardial blood flow. Circulation 1997;96:2325-31.
23. Maskali F, Poussier S, Marie PY, Tran N, Antunes L, Olivier P, et al. High-resolution simultaneous imaging of SPECT, PET, and MRI tracers on histologic sections of myocardial infarction. J Nucl Cardiol 2005;12:229-30.
24. 99mTc-DTPA autoradiography in rats. Radiology 1999;211:698-708.
25. 201Tl during dobutamine infusion. Comparison with adenosine stress. Circulation 1999;100:1653-9.
26. Glover DK, Ruiz M, Bergmann EE, Simanis JP, Smith WH, Watson DD, et al. Myocardial technetium-99m-teboroxime uptake during adenosine-induced hyperemia in dogs with either a critical or mild coronary stenosis: comparison to thallium-201 and regional blood flow. J Nucl Med 1995;36:476-83.
27. 99mTc sestamibi uptake during adenosine-induced vasodilation as a function of coronary stenosis severity. Circulation 1995;91:813-20.
28. 201Tl and regional myocardial blood flow. Circulation 1997;96:2332-8.
29. Boyle MP, Weisman HF. Limitation of infarct expansion and ventricular remodeling by late reperfusion. Study of time course and mechanism in a rat model. Circulation 1993;88:2872-83.
30. Forman R, Kirk ES. Thallium-201 accumulation during reperfusion of ischemic myocardium: dependence on regional blood flow rather than viability. Am J Cardiol 1984;54:659-63.
31. Whalen DA, Hamilton DG, Ganote CE, Jennings RB. Effect of a transient period of ischemia on myocardial cells. I. Effects on cell volume regulation. Am J Pathol 1974;74:381-97.
32. Inoue S, Murakami Y, Ochiai K, Kitamura J, Ishibashi Y, Kawamitsu H, et al. The contributory role of interstitial water in Gd-DTPA-enhanced MRI in myocardial infarction. J Magn Reson Imaging 1999;9:215-9.
33. Bremerich J, Wendland MF, Arheden H, Wyttenbach R, Gao DW, Huberty JP, et al. Microvascular injury in reperfused infarcted myocardium: noninvasive assessment with contrast-enhanced echoplanar magnetic resonance imaging. J Am Coll Cardiol 1998;32:787-93.
34. Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H, et al. Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 2000;36:1202-9.
35. Shintani Y, Ito H, Iwakura K, Kawano S, Tanaka K, Masuyama T, et al. Usefulness of impairment of coronary microcirculation in predicting left ventricular dilation after acute myocardial infarction. Am J Cardiol 2004;93:974-8.